A Study to Assess the Safety and Efficacy of ASP8062 as an Add-on Therapy to Buprenorphine/Naloxone in Participants With Opioid Use Disorder
Condition:   Opioid Use Disorder Interventions:   Drug: ASP8062;   Drug: Placebo ASP8062;   Drug: buprenorphine/naloxone Sponsor:   Astellas Pharma Global Development, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2021 Category: Research Source Type: clinical trials